Skip to content

D&A at other companies

Cadence Design Systems logo
Cadence Design SystemsCDNS
$84.62M+59.9%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
$19.67M+1.8%
Absci Corporation logo
Absci CorporationABSI
$2.73M-11.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$5.92M+34.2%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$504K-58.3%
Certara, Inc. logo
Certara, Inc.CERT
$19.09M+2.6%

Other financials

Income statement

See full
Revenue$58.6M-1.6%
Gross profit$29.5M-5.1%
Operating income-$48.8M+4.1%
Net income-$60.0M-0.4%
EPS (diluted)-$0.81+1.2%

Balance sheet

See full
Cash & equivalents$267.7M-20.7%
Total debt$107.0M-7.9%
Total equity$313.5M-16.1%
Total assets$634.2M-14.6%

Cash flow

See full
Operating cash flow-$14.8M-110%
CapEx$2.5M+321%
Free cash flow-$17.3M-112%

Valuation

See full
Market cap$1.15B-23.7%
Enterprise value$984.71M-23.1%
P/S4.5×-2.0×

Profitability

See full
Gross margin55.3%-7.3pp
Operating margin-64.7%-12.0pp
Net margin-68.5%
FCF margin9.6%+5.1pp

Returns & leverage

See full
Return on equity-45.7%
Debt / equity0.3×0.0×
Current ratio2.7×-0.7×

Where this comes from

Reported directly by Schrodinger in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: Schrodinger’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Schrodinger's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Schrodinger's D&A?
Schrodinger (SDGR) reported D&A of $1.48M in Q1 2026.
How has Schrodinger's D&A changed year-over-year?
Schrodinger's D&A decreased by 7.1% year-over-year, from $1.59M to $1.48M.
What is the long-term trend for Schrodinger's D&A?
Over 4 years (2021 to 2025), Schrodinger's D&A has grown at a 20.6% compound annual growth rate (CAGR), from $2.85M to $6.02M.
What does D&A mean?
Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.